PreveCeutical closes $200,000 third tranche of non-brokered private placement at $0.025 per unit

• PreveCeutical Medical closed a third tranche of a non-brokered private placement, issuing 8,000,000 units at $0.03 for $200,000.
• Total proceeds from three tranches reached $785,000, including $340,000 raised on May 12, 2026, and $245,000 on June 12, 2026.
• Each unit includes one common share, plus a half-warrant exercisable at $0.05 for two years from the June 12, 2026 closing.
• Paid a $19,600 finder fee, issued 784,000 advisory commission warrants at $0.05 with the same term.
• Proceeds earmarked for payables, operating expenses, general working capital; additional tranches targeted within four weeks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Preveceutical Medical Inc. published the original content used to generate this news brief on July 27, 2026, and is solely responsible for the information contained therein.